Relevance of bone marrow features in the differential diagnosis between essential thrembocythemia and early stage idiopathic myelofibrosis

Haematologica

Volumn 85, Issue 11, 2000, Pages 1126-1134

  Thiele, J ^a   Kvasnicka, H M ^a   Zankovich, R ^a   Diehl, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bone marrow biopsies; Diagnostic criteria; Early myelofibrosis; Essential thrombocythemia; Megakaryopoiesis; Survival

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW BIOPSY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEGAKARYOPOIESIS; MYELOFIBROSIS; SPLENOMEGALY; SURVIVAL TIME; THROMBOCYTHEMIA;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; ERYTHROPOIESIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEGAKARYOCYTES; MIDDLE AGED; MYELOFIBROSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 0033656596     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Essential thrombocythemia: Clinical and laboratory characteristics at presentation
2. Essential thrombocythemia: An interim report From the Polycythemia Vera Study Group
3. Primary thrombocyrhemia
4. Diagnosis and classification of erythrocytoses and thrombocytoses
5. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocyrhemia
6. Normal life expectancy and thrombosis-Free survival in aspirin treated essential thrombocythemia
7. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders
8. Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis
9. Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis
10. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
11. Essential thrombocythemias. Clinical evolutionary and biological data
12. Essential thrombocythemia. Clinical characteristics and course of 61 cases
13. Clinical course of essential thrombocythemia in 147 cases
14. Incidence and risk Factors For thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia
15. Essential thrombocythemia: A retrospective study on the clinical course of 100 patients
16. Thromboric and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients
17. Primary thrombocythemia: Diagnosis, clinical manifestations and management
18. Interferon-α therapy in polycythemia vera and essential thrombocythemia
19. No treatment For low-risk thrombocythaemia: Results from a prospective study
20. Alfa-interferon in the treatment of essential thrombocythemia: Clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone
21. Essential thrombocythemia at diagnosis: Causes of diagnostic evaluation and presence of positive diagnostic findings
22. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group
23. Prognostic significance of bone marrow biopsy in essential thrombocythemia
24. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis - Features of significance for the diagnosis of primary (essential) thrombocythemia
25. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts
26. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD)
27. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes
28. Idiopathic primary osteo-myelofibrosis: A clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact
29. Classification and staging of Ph-negative myeloproliferatire disorders by histopathology From bone marrow biopsies
30. The immunohistological detection of platelet, megakaryocytes and thrombi in routinely processed specimens
31. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
32. Estimating the expectation of life in cancer survival studies with incomplete follow-up information
33. Cancer survival corrected for heterogeneity in patient withdrawal
34. Prognostic Factors in idiopathic (primary) osteomyelofibrosis
35. The histopathology of chronic myeloproliferative diseases
36. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies
37. Variable expression of features of normal and neoplastic stem cells in patients with thrombocytosis
38. Clonal analysis of haematopoietic cells in essential thrombocythaemia
39. Acute transformation in nonleukemic chronic myeloproliferative disorders: Actuarial probability and main characteristics in a series of 218 patients
40. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis
41. Myelofibrosis in chronic myeloproliferative disorders. Incidence among sub-types according to the Hannover Classification
42. Agnogenic myeloid metaplasia (AMM) - Correlation of bone marrow lesions with laboratory data: A longitudinal pathological study on 114 patients
43. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis
44. Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients
45. Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival
46. Prognostic factors on agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system
47. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis - A critical evaluation of clinical and histomorphological data
48. Chronic myeloproliferative disorders in bone marrow biopsies
49. 9/L be used as a diagnostic criterion in essential thrombocythaemia?. An analysis of the natural course including early stages
50. 9/L